Current Advances in Chronic Kidney Disease in Children: Growth, Cardiovascular, and Neurocognitive Risk Factors

Larry A. Greenbaum, Bradley A. Warady, Susan L. Furth

Research output: Contribution to journalArticle

Abstract

Linear growth and neurocognitive development are two of the most important differences between adults and children, in terms of clinical issues that must be addressed in patients with chronic kidney disease (CKD). Correction of metabolic acidosis, nutritional deficiency, and renal osteodystrophy improve linear growth, but many children require administration of growth hormone to achieve normal growth. A variety of neurocognitive deficits occur in children with CKD, although there has been an improvement in outcome via improved dialysis, correction of malnutrition, and decreased aluminum exposure. Although growth and neurocognitive development are delayed, cardiovascular complications are accelerated in children with CKD, and are reflected in a dramatic increase in cardiovascular mortality compared with healthy children. Other early cardiovascular complications in children with CKD include left ventricular hypertrophy, cardiac dysfunction, and vascular calcifications.

Original languageEnglish (US)
Pages (from-to)425-434
Number of pages10
JournalSeminars in Nephrology
Volume29
Issue number4
DOIs
StatePublished - Jul 2009

Fingerprint

Chronic Renal Insufficiency
Growth
Growth and Development
Malnutrition
Chronic Kidney Disease-Mineral and Bone Disorder
Vascular Calcification
Left Ventricular Hypertrophy
Acidosis
Aluminum
Growth Hormone
Dialysis
Mortality

Keywords

  • cardiovascular diseases
  • Chronic kidney failure
  • developmental disabilities
  • human growth hormone

ASJC Scopus subject areas

  • Nephrology

Cite this

Current Advances in Chronic Kidney Disease in Children : Growth, Cardiovascular, and Neurocognitive Risk Factors. / Greenbaum, Larry A.; Warady, Bradley A.; Furth, Susan L.

In: Seminars in Nephrology, Vol. 29, No. 4, 07.2009, p. 425-434.

Research output: Contribution to journalArticle

Greenbaum, Larry A. ; Warady, Bradley A. ; Furth, Susan L. / Current Advances in Chronic Kidney Disease in Children : Growth, Cardiovascular, and Neurocognitive Risk Factors. In: Seminars in Nephrology. 2009 ; Vol. 29, No. 4. pp. 425-434.
@article{9f875a17841c4c2fb97a69775692da89,
title = "Current Advances in Chronic Kidney Disease in Children: Growth, Cardiovascular, and Neurocognitive Risk Factors",
abstract = "Linear growth and neurocognitive development are two of the most important differences between adults and children, in terms of clinical issues that must be addressed in patients with chronic kidney disease (CKD). Correction of metabolic acidosis, nutritional deficiency, and renal osteodystrophy improve linear growth, but many children require administration of growth hormone to achieve normal growth. A variety of neurocognitive deficits occur in children with CKD, although there has been an improvement in outcome via improved dialysis, correction of malnutrition, and decreased aluminum exposure. Although growth and neurocognitive development are delayed, cardiovascular complications are accelerated in children with CKD, and are reflected in a dramatic increase in cardiovascular mortality compared with healthy children. Other early cardiovascular complications in children with CKD include left ventricular hypertrophy, cardiac dysfunction, and vascular calcifications.",
keywords = "cardiovascular diseases, Chronic kidney failure, developmental disabilities, human growth hormone",
author = "Greenbaum, {Larry A.} and Warady, {Bradley A.} and Furth, {Susan L.}",
year = "2009",
month = "7",
doi = "10.1016/j.semnephrol.2009.03.017",
language = "English (US)",
volume = "29",
pages = "425--434",
journal = "Seminars in Nephrology",
issn = "0270-9295",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Current Advances in Chronic Kidney Disease in Children

T2 - Growth, Cardiovascular, and Neurocognitive Risk Factors

AU - Greenbaum, Larry A.

AU - Warady, Bradley A.

AU - Furth, Susan L.

PY - 2009/7

Y1 - 2009/7

N2 - Linear growth and neurocognitive development are two of the most important differences between adults and children, in terms of clinical issues that must be addressed in patients with chronic kidney disease (CKD). Correction of metabolic acidosis, nutritional deficiency, and renal osteodystrophy improve linear growth, but many children require administration of growth hormone to achieve normal growth. A variety of neurocognitive deficits occur in children with CKD, although there has been an improvement in outcome via improved dialysis, correction of malnutrition, and decreased aluminum exposure. Although growth and neurocognitive development are delayed, cardiovascular complications are accelerated in children with CKD, and are reflected in a dramatic increase in cardiovascular mortality compared with healthy children. Other early cardiovascular complications in children with CKD include left ventricular hypertrophy, cardiac dysfunction, and vascular calcifications.

AB - Linear growth and neurocognitive development are two of the most important differences between adults and children, in terms of clinical issues that must be addressed in patients with chronic kidney disease (CKD). Correction of metabolic acidosis, nutritional deficiency, and renal osteodystrophy improve linear growth, but many children require administration of growth hormone to achieve normal growth. A variety of neurocognitive deficits occur in children with CKD, although there has been an improvement in outcome via improved dialysis, correction of malnutrition, and decreased aluminum exposure. Although growth and neurocognitive development are delayed, cardiovascular complications are accelerated in children with CKD, and are reflected in a dramatic increase in cardiovascular mortality compared with healthy children. Other early cardiovascular complications in children with CKD include left ventricular hypertrophy, cardiac dysfunction, and vascular calcifications.

KW - cardiovascular diseases

KW - Chronic kidney failure

KW - developmental disabilities

KW - human growth hormone

UR - http://www.scopus.com/inward/record.url?scp=67650150956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650150956&partnerID=8YFLogxK

U2 - 10.1016/j.semnephrol.2009.03.017

DO - 10.1016/j.semnephrol.2009.03.017

M3 - Article

C2 - 19615563

AN - SCOPUS:67650150956

VL - 29

SP - 425

EP - 434

JO - Seminars in Nephrology

JF - Seminars in Nephrology

SN - 0270-9295

IS - 4

ER -